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Background: According to the International Association for the Study of Pain (IASP), the term temporomandibular
disorder (TMD) regards a subgroup of orofacial pain, the symptoms of which include pain or discomfort in the
temporomandibular joint, ears, masticatory muscles and neck on one or both sides, as well as joint sounds, limited
mandibular movements or mandibular deviation and difficulties chewing. Phototherapy, such as low-level laser
therapy (LLLT) and light-emitting diode (LED) therapy, is one of the resources used to treatment muscle pain.
Thus, there is a need to investigate therapeutic resources that combine different wavelengths as well as different
light sources (LLLT and LED) in the same apparatus.
The aim of the proposed study is to evaluate the effects of four different doses of phototherapy on pain, activity of the
masticatory muscles (masseter and bilateral anterior temporal) and joint mobility in individuals with
temporomandibular disorder. A further aim is to determine the cumulative effect 24 and 48 hours after a single session.
Methods/Design: A placebo-controlled, double-blind, randomized, clinical trial will be carried out involving 72 women
between 18 and 40 years of age with a diagnosis of myogenous TMD. The participants will then be randomly allocated
to four groups totaling 18 individuals per group. Three groups will be submitted to a single session of phototherapy
with different light sources, and one group will receive placebo therapy: Group A (2.62 Joules); Group B (5.24 Joules);
Group C (7.86 Joules); and Group D (0 Joules). The following assessment tools will be administered on four separate
occasions (baseline and immediately after, 24 h after and 48 h after phototherapy). Pain intensity will be
assessed using the visual analog scale for pain, while pain thresholds will be determined using algometer, and
electromyographic (EMG) analysis on the masseter and anterior temporal muscles.
Discussion: The study will contribute to the practice of the evidence-based use of phototherapy in individuals
with a myogenous TMD. Data will be published after the study is completed.
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Trial registration: This study is registered with the Brazilian Registry of Clinical Trials, NCT02018770, date of
registration: 7 December 2013.
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According to the International Association for the Study
of Pain (IASP) [1], the term temporomandibular dis-
order (TMD) regards a subgroup of orofacial pain, the
symptoms of which include pain or discomfort in the
temporomandibular joint, ears, masticatory muscles
and neck on one or both sides, as well as joint sounds,
limited mandibular movements or mandibular devi-
ation and difficulties chewing. Muscle pain is one of
the most common and limiting clinical manifestations
of this condition [2-5]. The main causes of TMD are
trauma involving local tissues, chronic repetitive micro-
trauma, non-habitual use of the mandible and an increase in
emotional stress [6]. With regard to prevalence, it is esti-
mated that 20% of the population worldwide have TMD,
but only 10 to 20% of affected individuals seek some
form of treatment [7,8]. Phototherapy, such as low-
level laser therapy (LLLT) and light-emitting diode (LED)
therapy, is one of the resources used by dentists and phys-
iotherapists to treat TMD. Due to the low energy intensity
and wavelengths capable of penetrating biological tissues,
LLLT is believed to influence the synthesis, release and
metabolism of numerous signaling substances involved in
analgesia [9,10]. This resource is reported to lead to an
increase in the level of beta-endorphins, a reduction in
bradykinin, a reduction in the release of histamine, an
increase in lymphatic flow, reductions in swelling and
pain-related substances, an increase in blood supply, a
reduction in the duration of inflammation and the in-
duction of muscle relaxation [11,12]. LED therapy has
been used for the same purposes and has demonstrated
similar results, while offering the advantages of a lower
cost and greater equipment durability [13,14]. How-
ever, an exhaustive review of the literature has revealed
no studies involving the use of phototherapy with dif-
ferent light sources (LLLT and LED) on the same device
for application to the masseter and temporal muscles
in individuals with myogenous TMD. Knowledge re-
garding the clinical effects of these forms of photo-
therapy can contribute to the indication of the best
therapeutic resource for such patients. the use of thera-
peutic appliances that combine different sources of light
may be advantageous, especially as devices with this
feature began to be available in recent years commer-
cially, making it necessary to research primarily on ef-
fects and the choice of best parameters, primarily
analyzing immediate effect to later assess cumulativedose effects on the masticatory muscles in patients
with TMD.
The aim of the proposed study is to evaluate the ef-
fects of four different doses of phototherapy (0, 2.62,
5.24 and 7.86 Joules) on pain, activity of the masticatory
muscles (massester and bilateral anterior temporal) and
joint mobility in individuals with temporomandibular dis-
order (TMD). A further aim is to determine the cumula-
tive effect 24 and 48 hours after a single session. The
hypothesis is that individuals with TMD submitted to
phototherapy with different light sources (LLLT and LED)
contained in a single device with a dose of 7.86 will ex-
perience a greater reduction in pain and change in
electromyographic activity of the masticatory muscles
in comparison to individuals submitted to lower doses
and the effects of a single session of phototherapy will
be maintained for 24 and 48 hours.
Methods/Design
Overview of research design
A double-blind, placebo-controlled, randomized, clinical
trial is proposed to compare the effects of different doses
of phototherapy in individuals with myogenous TMD.
After screening, individuals with myogenous TMD (based
on the Research Diagnostic Criteria for Temporoman-
dibular Disorders (RDC/TMD) will be selected. The
following evaluations and assessment tools will be ad-
ministered: visual analog scale (VAS), algometry for pain,
and electromyographic (EMG) analysis. Seventy-two indi-
viduals will be allocated to different groups (18 individuals
per group) through a randomization process involving
opaque envelopes containing cards stipulating one of the
three following groups: A (2.62 Joules), B (5.24 Joules), C
(7.86 Joules) and D (0 Joules). The study will be divided
into three evaluation phases and a treatment phase:
Initial evaluation
The individuals who meet the eligibility criteria will undergo
an initial evaluation in the following sequence: VAS, algome-
try for pain and EMG analysis on the masseter and anterior
temporal muscles.
Treatment phase
Following randomization, the phototherapy will be car-
ried out on the masseter and temporal muscles that are
presenting pain.
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Immediately after, 24 hours after and 48 hours after the
end of the treatment phase, the final evaluations will be
performed, following the same sequence used in the ini-
tial evaluation (Figure 1).
Blinding
The participants will be blinded to the allocation. A re-
searcher will be responsible for the randomization process
and programming of the phototherapy device based on
the results of the randomization. A second researcher will
perform the phototherapy and will be blinded to the doses
and allocation of the participants. These researchers will
not participate in the evaluations, which will be performed
by a third researcher blinded to the allocation of the par-
ticipants. The statistician will also be blinded to the alloca-
tion of the participants until the end of the statistical
analyses.
Inclusion criteria
All volunteers will have a diagnosis of myogenous TMD
based on the RDC/TMD, with moderate to severe pain
in the masseter and temporal muscles being rated by an








Figure 1 Flow chart of experimental design.index of all participants must be less than 25 kg/m2, as
the amount of adipose tissue between the electrode and
surface of the muscle can affect that reading of the elec-
tromyographic (EMG) signal [15]. All volunteers must
also have an initial pain score greater than 3 points on
the VAS [16].
Exclusion criteria
The exclusion criteria will be missing teeth, the use of den-
tures, systemic or neuromuscular diseases, a history of
trauma to the face or temporomandibular joint, history of
temporomandibular joint luxation, currently undergoing
orthodontic treatment, or currently undergoing medicinal
treatment that can affect the musculoskeletal system (anal-
gesic, anti-inflammatory agent or muscle relaxant).
Procedures
The proposed study will follow the recommendations of the
Consolidated Standards of Reporting Trials (CONSORT)
statement to ensure greater transparency and quality of the
findings. The participants will receive information on the
objectives and the eligibility criteria of the study, and will
subsequently provide informed consent. For eligible partici-
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tion of the patients to the different groups. The following as-
sessment tools will be applied: 1) RDC/TMD questionnaire
for the diagnosis and inclusion of the participants; 2) EMG;
3) VAS for pain; and 4) an algometer. Detailed descriptions
of each of these tools are offered below.
Diagnosis of temporomandibular disorder
The RDC/TMD will be used for the diagnosis of TMD
[17], which classifies individuals into three main groups:
I) muscle disorder; II) disc displacement; and III) other
joint conditions (Table 1). Each participant may be clas-
sified in one, two or three groups simultaneously. As
pain will be the primary outcome of the study, all volun-
teers will need to have myofacial pain. Therefore, the
RDC/TMD will be used to determine whether the vol-
unteers meet this inclusion criterion. The RDC/TMD
has two axes. Axis I consists of a clinical exam, which
will be performed by a single examiner having previously
undergone a training and calibration exercise in compli-
ance with the specifications of the International RDC/
TMD Consortium. This exam addresses the presence ofTable 1 Classification and diagnosis of
temporomandibular disorder subgroups based on
Research Diagnostic Criteria for Temporomandibular
Disorders
Group Subgroup
I A. Myofascial pain
B. Myofascial pain with limited opening
No group I diagnosis
II right A. Disk displacement with reduction
B. Disk displacement without reduction with
limited opening
C. Disk displacement without reduction
without limited opening
No group II diagnosis
II left A. Disk displacement with reduction
B. Disk displacement without reduction with
limited opening
C. Disk displacement without reduction without
limited opening
No group II diagnosis
II right A. Arthralgia
B. Osteoarthritis of temporomandibular joint
syndrome (TMJ)
C. Osteoarthritis of TMJ
No group III diagnosis
II left A. Arthralgia
B. Osteoarthritis of TMJ
C. Osteoarthritis of TMJ
No group III diagnosisspontaneous muscle and joint pain, maximum mouth
opening, mandibular range of motion, joint sounds and
pain sensitivity during mandibular movements or upon
palpation of the muscles and/or joint. Average duration
for the application of Axis I is 20 minutes. The volunteer
will be seated in a chair with the trunk erect, back com-
pletely supported, feet on the floor and hands supported
on the thighs, with the Frankfurt plane parallel to the
ground. The examiner will be positioned in front of the
volunteer. Axis II classifies individuals based on the de-
gree of chronic pain, depression and nonspecific physical
symptoms. This axis will be self-administered following
the clinical exam in a well-lit, climate-controlled room
with no time constraints.
Electromyography
Electromyography (EMG) activity of the right and left mas-
seter and anterior temporal muscles will be recorded using
disposable, active surface electrodes (Ag/AgCl - Noraxon™-
http://www.noraxon.com/ webcite - 15770 N. Greenway-
Hayden Loop, #100Scottsdale, AZ 85260. Phone: 480-443-
3413) attached to the belly of the muscles in the region of
greatest volume determined during moderate jaw clench-
ing. The skin surface will be cleaned with cotton soaked in
70% alcohol to diminish impedance [15]. A metallic rect-
angular reference electrode measuring 3 × 2 cm coated
with Lectron II conductive gel (Pharmaceutical Innova-
tions™ http://www.pharminnovations.com webcite - 897
Frelinghuysen Ave Newark, NJ 07114 (973) 242–2903) to
enhance the conduction capacity and impede interference
from external noise will be attached to the left wrist of
each participant.
The EMG signals will be collected with the aid of an
eight-channel electromyograph (830 C module, EMG
System do Brazil Ltda™)- http://www.emgsystem.com.br
webcite - Rua Porto Principe, 50 - Vila RubiCEP12245-
572-São José dos Campos/SP. Phone: 55 12 3922-4069/
55 12 3942–4736)) using a band-pass filter with a cutoff
frequency of 20 to 1000 Hz and common-mode rejec-
tion ratio >120. All data will be collected and processed
using 16-bit analog-digital converter (EMG System do
Brazil Ltda™ - http://www.emgsystem.com.br webcite -
Rua Porto Principe, 50 - Vila RubiCEP12245-572-São
José dos Campos/SP. Phone: 55 12 3922-4069/55 12
3942–4736))) with a sampling frequency of 2 kHz. The
signal capturing module will be connected to a stand-
ard laptop computer with a compatible data acquisi-
tion program.
The volunteer will be seated in a chair, with the back com-
pletely supported, eyes open, feet parallel on the a rubber
mat and arms supported on the thighs. The exam will be
carried out under three conditions: 1) in the normal postural
position with the mandible at rest; 2) during maximum vol-
untary contraction (MVC) with Parafilm M™ placed between
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(MHC) with no material placed between the teeth. In the
normal postural position, the volunteer will remain with the
mandible relaxed, teeth apart and lips in contact for 15 s.
For the MVC, the volunteer will be instructed to position
Parafilm M™ between the upper and lower premolars, first
molars and second molars bilaterally and perform isometric
contraction for 5 s following a verbal command. For the
MHC, the same procedure will be performed without the
use of M™ for 5 s. Under each condition, three readings will
be made with a 2-minute rest interval between readings to
avoid fatigue.
Electromyography signal processing
The root mean square (RMS), median frequency, asym-
metry index and co-contraction index will be used as
the parameters for the interpretation of the signal pro-
cessing. The signals will be processed using specific rou-
tines developed with the aid of the Matlab program,
version 7.1 (The MathWorks Inc., Massachusetts, USA).
The RMS of the signal (expressed in μV) obtained at rest and
during MHC will be normalized by the largest RMS obtained
during three readings of MVC (μmV/μV × 100: %MVC).
With the mandible at rest, the RMS will be calculated for
the entire 15 s of the signal collected. Data on MHC will
be analyzed based on Ferrario et al. [18], with the first
and last second of the raw EMG signal being discarded
and the RMS being calculated using a 25-ms moving
window without overlap for the 3 s of signal selected.
The overlap percentage coefficient (OPC, unit: %) de-
scribed by Ferrario et al. [18] will be used to evaluate
the distribution of muscle activity in time and the ampli-
tude determined by the occlusion. Symmetric distribu-
tion of muscle activity determined by the OPC will be
analyzed considering variability between 0% (absence of
symmetry) and 100% (perfect symmetry). Lateral excur-
sion (potential given by imbalanced contractile activities
of the contralateral masseter and temporal muscles) will
be evaluated using the torque coefficient (TC, unit: %)
considering variability between 0% (absence of lateral ex-
cursion force) and 100% (maximum lateral excursion
force).
The EMG signal of the paired muscles under each
situation recorded during MHC will be compared by cal-
culating a percentage of OPC and TC. Mean normalized
EMG activity (%MVC) of the right and left masseter and
temporal muscles will be calculated and used for com-
parisons among evaluation times (pre-treatment, imme-
diate post-treatment and late post-treatment).
Visual analog scale
A visual analog scale (VAS) allows the quantification of pain
intensity. This scale consists of a straight line measuring
10 cm in length, with ‘absence of pain’ written at one endand ‘worst pain ever felt’ written at the other end. The
volunteer will be instructed to make a perpendicular
line between the two extremes that represents the pain
level he/she is feeling at the time [19].Algometry
A digital algometer (DD-200, Instrutherm™) will be used
to evaluate pain through the application of pressure. For
such, the volunteer will be seated in a chair, trunk erect,
back completely supported, feet on floor and hand on
thighs, respecting the Frankfurt plane. The researcher
will position the algometer and apply gradual pressure at
three points over the masseter muscle (upper, middle and
lower), three points over the temporal muscle (posterior,
middle and anterior) and over the lateral pole (bilaterally)
based on the findings of the clinical exam (palpation) of
the RDC/TMD. Pressure will be applied to all points until
the volunteer reports feeling pain. The value registered on
the display of the algometer will then be recorded. If the
volunteer does not feel pain, maximum pressure will not
exceed 4 Kgf [20]. Pressure will be applied using the rub-
ber tip measuring 1 cm2 in direct contact with the skin at
the ‘fast’ velocity of the ‘peak hold’ function (specification
of the DD-200 digital algometer, Instrutherm™). Prior to
the readings, the algometer will be applied to the volun-
teer’s arm to familiarize him/her with the procedure. The
volunteer will be instructed to raise his/her hand to indi-
cate the exact instant of pain, at which point the re-
searcher will cease to apply the pressure. The algometer
will be applied only once to each of the aforementioned
points and a 30-s rest interval will be given between
readings.Phototherapy
The portable PainAway™ nine-diode cluster (Multi Radiance
Medical®, Solon, OH, USA) will be employed. This system
has one 905 nm laser diode, four 875 nm LED diodes and
four 670 nm LED diodes. The aperture size of device is
4 cm2 (Table 2).
For the blinding of the participants, the phototherapy
equipment with the different light sources has two iden-
tical application hand pieces provided by the manufac-
turer - one with an active tip and the other for placebo
applications (does not emit energy), but both with the
same sound device. The tips will be denominated X and
Y by a researcher who will not participate in the applica-
tion or evaluations. The researchers who will administer
the phototherapy procedures and those in charge of the
evaluations will be blinded to which hand piece has the
active effect and which is for the placebo application.
The hand pieces will only be identified at the end of the
data collection process. Table 2 displays the doses and
application times for each group.
Table 2 Phototherapy parameters
Number of super-pulsed lasers 1 Super-pulsed laser
Wavelength (nm) 905
Frequency (Hz) 1000
Average optical output (mW) 0.9
Peak power (W) 8.5
Dose (J) total per group (20s, 40s, 60s) 0.018; 0.036; 0.054
Spot size (cm2) 0.4
Number of red LEDs 4 Red
Wavelength (nm) 640(±10 nm)
Frequency (Hz) 2
Average optical output (mW)-each 15
Dose (J) each emitter per group (20s, 40s, 60s) 0.3; 0.6; 0.9
Dose (J) total per group (20s, 40s, 60s) 1.2; 2.4; 3.6
Spot size (cm2)-each 0.9
Number of infrared LEDs 4 infrared
Wavelength (nm) 875(±10 nm)
Frequency (Hz) 16
Average optical output (mW)-each 17.5
Dose (J) each emitter per group (20s, 40s, 60s) 0.35; 0.70; 1.05
Dose (J) total per group (20s, 40s, 60s) 1.4; 2.8; 4.2
Spot size (cm2)-each
Magnetic field (mT) 35
Treatment time (s) 20; 40 or 60
Aperture of device (cm2) 4
Total delivered energy (J) per point 2.62; 5.24 or 7.86
Total delivered energy (J) per individual 26.20; 52.40 or 78.60
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applied to two points of the masseter muscle bilaterally
and three points on the temporal muscle bilaterally
(totaling 10 application points), based on the results
of the clinical exam performed using the RDC/TMD.
The same points will be evaluated using an algometer.
Phototherapy will be applied by one of the researchers in
an isolated room with only the researcher and the volunteer
present. The researcher will receive the pre-programmed
hand piece. Both the researcher and volunteer will be wear-
ing eye protection equipment. The volunteer will be in the
supine position on a cot with lower limbs supported on a
roll of foam rubber measuring 20 cm in diameter and head
supported on a pillow to provide a comfortable resting pos-
ture. Phototherapy will be applied using the point technique
in contact with the skin with a beam area of 4 cm2 (device
aperture). The placebo group will be submitted to the same
procedures as the groups submitted to phototherapy. Only
the coordinator will have knowledge regarding the different
phototherapy and placebo applications. At the end of thestudy, the individuals in the placebo group will be submitted
to treatment with active phototherapy.
Sample size
The sample size was calculated considering α = 0.05 (5%
chance of a type I error), 1-β = 0.95 (% of sample power)
and data from a visual analog scale (VAS) reported in
the study by Pereira et al. [21]. The minimum number
for each group was determined to be 15 individuals, to
which 20% was added to compensate for possible drop-
outs during the study (total: 18 individuals per group).
This calculation was performed using the G*Power
software program [22]. Seventy-two individuals will be
allocated to different groups (18 individuals per group)
through a randomization process involving opaque en-
velopes containing cards stipulating one of the three follow-
ing groups: A (2.62 Joules), B (5.24 Joules), C (7.86 Joules)
and D (0 Joules).
Data analysis
Pain will be the primary outcome and will be determined
using a VAS and algometer. EMG will be the secondary
outcome. The independent variables will be the different
light sources used for phototherapy. The dependent vari-
ables will be derived from the pre-treatment and post-
treatment evaluations. Intra-group comparisons will be
performed using repeated-measures analysis of variance
(ANOVA or Friedman’s test), followed by either the Stu-
dent’s t-test or Wilcoxon’s test. Inter-group comparisons
will be performed using either one-way ANOVA or the
Kruskal-Wallis test. The choice of tests will be determined
by the distribution (normal or non-normal) of the data. The
level of significance will be set to 5% (P <0.05). All compari-
sons and statistical analyses will be performed using the
SPSS program, version 13.0 (Chicago, IL, USA). Cohen’s d
will be employed to determine the clinical effect size of the
proposed therapies, with the interpretation of the coeffi-
cients based on the classification established by Cohen [23]:
0.2 = small effect; ≥0.5 =moderate effect; ≥0.8 = large effect.
Ethics and data security
The proposed randomized, placebo-controlled, double-
blind trial received approval from the Human Research
Ethics Committee of the University Nove de Julho (Sao
Paulo, Brazil) under process number 18032013.4.0000.5511
dated 6 June 2013. All individuals will be asked to provide
written, informed consent prior to randomization, using
standard forms. The trial is registered with the World
Health Organization under Universal Trial in Clinical-
Trials.gov under the number NCT02018770.
Discussion
The findings are expected offer scientific evidence regard-
ing the importance of an effective conservative treatment
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in the clinical decision-making process when working
with such patients. Although a number of studies in the
literature have addressed different forms of treatment for
TMD [24-27] including phototherapy [28,29], gaps in
knowledge remain in clinical practice regarding the
use of different light sources (LLLT and LED), as well
as the most effective, evidenced-based doses.
In a systematic review, Melis et al. [30] found consider-
able methodological differences among studies, especially
with regard to the number of applications, duration and
characteristics (wavelength and frequency) of LLLT, dem-
onstrating the lack of standardized guidelines for effective
treatment. Thus, there is a need for further in-depth in-
vestigations regarding the use of phototherapy for the
treatment of myogenous TMD [24-27]. Pain is the main
symptom of this condition and muscle and joint involve-
ment are the most prevalent in the population [31], lead-
ing to limitations with regard to activities of daily living,
such as eating, speaking, yawning and smiling, as well as a
reduction in quality of life [32].
The study will contribute to the practice of evidence-
based use of phototherapy in individuals with a myogenous
TMD, and the effects of specific phototherapy parameters
can help optimize treatment strategies for reducing and
even eliminating the signs and symptoms of myogenous
TMD. Data will be published after the study is completed.Trial status
The proposed study is currently in the recruitment phase,
and individuals are being diagnosed with TMD using the
RDC-TMD questionnaire.
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